Fragment-based QSAR model toward the selection of versatile anti-sarcoma leads
Related Experiment Video
Updated: May 28, 2026
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Alejandro Speck-Planche1, Valeria V Kleandrova, Feng Luan
1Requimte/Department of Chemistry and Biochemistry, University of Porto, 4169-007 Porto, Portugal. alejspivanovich@gmail.com
Abstract:
A sarcoma is a type of cancer which is originated from the connective tissue cells. With the time, several sarcomas have become resistant to the current anti-tumoral drugs. Many works have been reported in order to explain some mechanisms of resistance in different types of sarcomas and around 2000 compounds have been tested as anti-sarcoma agents against several sarcoma cell lines. However, there is no an available methodology for the rational design of compounds with anti-sarcoma activity. The present work develops a unified fragment-based approach by employing a multi-target QSAR model for the efficient search and design of new anti-sarcoma agents against 12 sarcoma cell lines. The model was obtained with the use of a heterogeneous database of compounds and it was based on substructural descriptors. The percentages of correct classification of active and inactive compounds were higher than 85% in both cases. Also, the present approach provided the rapid extraction of substructural alerts responsible of anti-sarcoma profile by calculating the quantitative contributions of fragments to anti-sarcoma activity. To our knowledge, this is the first attempt to calculate the probabilities of anti-sarcoma activity of compounds against several sarcoma cell lines simultaneously, using a unified fragment-based QSAR model.
Insights
This study introduces a novel fragment-based approach for designing new anti-cancer drugs against sarcoma. The developed quantitative structure-activity relationship (QSAR) model efficiently predicts anti-sarcoma activity, aiding drug discovery.
Area of Science:
- Oncology
- Medicinal Chemistry
- Computational Biology
Background:
- Sarcomas, cancers of connective tissue, often develop resistance to existing anti-tumoral drugs.
- Drug resistance necessitates new therapeutic strategies and drug discovery methods.
- Current drug discovery lacks a systematic methodology for designing effective anti-sarcoma compounds.
Purpose of the Study:
- To develop a unified fragment-based approach for the rational design of novel anti-sarcoma agents.
- To create a multi-target quantitative structure-activity relationship (QSAR) model for predicting anti-sarcoma activity.
- To identify key structural features (substructural alerts) responsible for anti-sarcoma efficacy.
Main Methods:
- Utilized a heterogeneous database of compounds for model development.
- Employed a fragment-based approach with substructural descriptors.
- Developed a multi-target QSAR model to predict activity against 12 sarcoma cell lines simultaneously.
Main Results:
- Achieved high classification accuracy for active and inactive compounds (>85%).
- Enabled rapid identification of substructural alerts contributing to anti-sarcoma activity.
- Demonstrated the ability to calculate probabilities of anti-sarcoma activity across multiple cell lines.
Conclusions:
- The developed unified fragment-based QSAR model offers a powerful tool for the rational design of new anti-sarcoma drugs.
- This approach facilitates efficient drug discovery by identifying promising compounds and their active fragments.
- Represents a significant advancement in predicting anti-cancer drug efficacy against diverse sarcoma types.
